Invitrogen™ SARS-CoV-2 Envelope (aa1-75), His-Avi Tag Recombinant Protein

Catalog No.	Quantity
PIRP87682	100 μg

Catalog No. PIRP87682 Supplier Invitrogen™ Supplier No. RP87682

Description

Recombinant Protein

Description: Recombinant 2019-nCoV envelope Protein is produced by E. coli expression system.

The SARS-CoV-2 envelope (E) protein is a small, integral membrane protein involved in several aspects of the virus' life cycle, such as assembly, budding, envelope formation, and pathogenesis.

Specifications

• Concentration: 0.47 mg/mL
• For Use With (Application): Control, ELISA, Western Blot
• Formulation: 20 mM tris with 0.5% Triton X-100, 250 mM NaCl and no preservative; pH 8
• Gene ID (Entrez): 43740570
• Molecular Weight (g/mol): 11.4 kDa
• Name: SARS-CoV-2 Envelope (aa1-75), His-Avi Tag
• Quantity: 100 μg
• Source: E. coli
• Regulatory Status: RUO
• Endotoxin Concentration: <0.1 EU/ μg
• Gene Alias: COVID19 Envelope Protein
• Common Name: SARS-CoV-2 Envelope Protein
• Biological Activity: Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Envelope (at 2 μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid with a linear range of 1.2-41.1 ng/mL)
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Protein Tag: His-tag, Avi-tag
• Sequence: SARS-CoV-2 Envelope Protein, amino acids Met1-Val75 (Accession # QHD43418.1)
• Content And Storage: -80°C
• Expression System: E. coli
• Form: Liquid
• Purity or Quality Grade: >95% by SDS-PAGE

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov